KR102033466B1 - 1,5-anhydroglucitol measurement means and a method of manufacturing the same - Google Patents

Abstract

The present invention provides a glucose removal reagent coated with a glucose removal reagent for converting glucose in a whole blood sample into glucose-6-phosphate in the 1,5-anhydroglucitol measuring means and a method for preparing the same. Glycitol reaction reagent is formed by the formation of oxides by the peroxide reaction from the hydrogen peroxide (H ₂ O ₂ ) produced through the enzymatic reaction with the layer, 1,5- anhydroglucitol contained in the glucose-free sample Technical aspects include the step of forming the coated reaction layer. As a result, it is possible to color in the visible light region through an enzymatic reaction with 1,5-anhydroglucitol, and the concentration of 1,5-anhydroglucitol can be measured at a low cost and easily through a visible light measuring instrument. In addition, since glucose which causes the same enzymatic reaction as 1,5-anhydroglucinol can be removed from whole blood, 1,5-anhydroglucinol can be measured using whole blood as a sample as it is.

Description

1,5-anhydroglucitol measuring means and a method of manufacturing the same {1,5-anhydroglucitol measuring means and a method of manufacturing the same}

The present invention relates to a 1,5-anhydroglucitol measuring means and a method of manufacturing the same, and more particularly, to be developed in the visible light region through the enzymatic reaction with 1,5-anhydroglucitol, visible light The present invention provides a 1,5-anhydroglucitol measuring means capable of measuring the concentration of 1,5-anhydroglucitol inexpensively and simply through a measuring device, and a method of manufacturing the same.

1,5-anhydroglucitol (1,5-AG) is the second largest group of glucose derivatives in the blood of healthy people, following glucose. It is a very stable chemically and biochemically. Such 1,5-AG is unclear, stable in vivo, and rarely metabolized and excreted in the urine. In addition, the amount of supply, excretion, and metabolism is extremely low compared to the maintenance of the body, so there is almost no fluctuation of the daily 1,5-AG value in the blood and little effect of diet. 1,5-AG in the body is derived from food, blood 1,5-AG is reabsorbed in the kidneys, only a fraction of it is excreted in the urine. In normal people, the oral supply in daily life and the amount excreted in the urine are balanced, so the blood 1,5-AG value is almost constant for a long time. However, since 1,5-AG is structurally similar to glucose and competitively resorbed in the proximal renal tubules, the excretion of 1,5-AG is relatively increased in diabetic patients, resulting in a decrease in blood levels of 1,5-AG. Done.

In recent years, the number of diabetics has increased as the diet becomes more abundant. In order to prevent the complications of diabetic patients, it is necessary to maintain the blood sugar level close to the blood sugar level of a healthy person, and the blood glucose self-measuring device is widely used so that the patient can directly measure the blood sugar level. However, since blood glucose is changed by a meal, the glucose measurement needs to be frequently performed, which burdens the patient. In addition, the lack of knowledge makes it difficult to accurately interpret the glucose levels measured by patients, and it is not easy to strictly control blood glucose levels.

On the other hand, since 1,5-AG is hardly affected by meals, it is easier to measure blood glucose levels than glucose measurements, and the 1,5-AG test has the following clinical usefulness. First, blood levels are stable. 1,5-AG is almost unaffected by new production or metabolism, does not fluctuate daily or daily, and affects other external factors such as sex, age, race, liver function, hormones, diet, exercise, duration of diabetes and treatment. There is little effect, and it changes at a constant rate according to the degree of urine sugar excretion. Second, the sample constraints are small. HbA1c is affected by hemolysis and fructosamine is affected by albumin or bilirubin concentrations, whereas 1,5-AG is not affected by hemolysis or ischemia and has no effect on diet, exercise or daily fluctuations. Sample collection is possible. Third, 1,5-AG is well correlated with other plasma regulatory indicators and is sensitive to blood glucose changes. Therefore, it becomes an early alarm of blood sugar worsening, and can be used in place of or in addition to the existing glycemic control indicators as a reliable test for blood sugar control monitoring. Fourth, the treatment effect can be evaluated quickly by reflecting glycemic control within a relatively short time. In other words, 1,5-AG is more sensitive and faster than conventional indicators as urinary excretion increases, so it responds sensitively to the current or immediate blood glucose control situation in real time and detects failure in blood glucose control early. Therefore, appropriate measures can be taken. Fifth, 1,5-AG also suggests increased intermittent hyperglycemia and urinary excretion. In diabetic patients, reducing the number of hyperglycemia and maintaining stable blood glucose is very important for treatment and prognosis, since HbA1c or fructosamine only provide average information on blood sugar control over a relatively long period of time. Measurement is more useful. Sixth, the range of measurement values is wide. 1,5-AG is so variable that it is easy to detect subtle changes in glycemic control in patients with mild hyperglycemic regions with near-normal blood glucose levels. Seventh, the sensitivity and specificity in the diagnosis of diabetes can be said to be an ideal test.

Conventional methods for measuring 1,5-AG include gas chromatography or liquid chromatography, but these methods are too cumbersome and are not commonly used as routine tests in hospital laboratories. Recently, test kits have been introduced that can be measured by removing the interference of glucose with enzymes. The test kit reflects the blood glucose control state of the diabetic patient for the past week, and is a self-measurement kit that allows the diabetic patient to accurately determine his or her blood glucose control state by measuring only once a week. Although the 1,5-AG self-measurement kit provides a great merit to the patient, the conventional 1,5-AG measurement method uses a sample of serum or plasma that requires separation of blood cells, and the amount of sample required for measurement It is not suitable for self-measurement. Therefore, a 1,5-AG self-measurement kit using a small amount of whole blood as a sample has not been realized.

Korea Patent Office Registered Patent No. 10-1470661

Accordingly, an object of the present invention is to develop a color in the visible light region through an enzyme reaction with 1,5-anhydroglucitol, and to measure the concentration of 1,5-anhydroglucitol inexpensively and simply through a visible light meter. It is to provide a 1,5-anhydroglucitol measuring means and a method for producing the same.

In addition, since glucose, which causes the same enzymatic reaction as 1,5-anhydroglucitol, can be removed from whole blood, 1,5-eye can be measured using whole blood as a sample as it is. It is to provide a hydroglucinol and a method for producing the same.

The above object is a glucose removal layer coated with a glucose removal reagent for converting glucose in a whole blood sample to glucose-6-phosphate, and 1,5-anhydrous contained in the glucose-removed sample. Forming a reaction layer coated with a glutathione reagent, which is formed by the oxidation of the peroxide reaction from hydrogen peroxide (H ₂ O ₂ ) produced by the reaction between the glycitol and the enzyme to form a reaction layer It is achieved by a method for preparing the 5-5-hydrohydrogitol measuring means.

In the whole blood sample, it is preferable that the amount of 1,5-anhydroglucitol is measured by moving the glucose removing layer and the reaction layer in a horizontal direction.

Here, the step of immersing the glucose removing body in the glucose removing reagent to form the glucose removing layer; Forming a reaction layer by immersing a glutathione reaction body in the glutathione reaction reagent; Combining the glucose removing layer and the reaction layer, and combining the glucose removing layer and the reaction layer comprises laminating one end of the glucose removing layer and one end of the reaction layer formed along a longitudinal direction. It is preferable to combine as much as possible.

The glucose eliminating reagent includes a buffer, a promoter, a glucose converting enzyme and a reverse reaction eliminating reagent, and the glucose converting enzyme for converting glucose into glucose-6-phosphate includes hexokinase, glucokinase and glucokinase thereof. The reverse reaction elimination reagent selected from the group consisting of the mixture and for removing the reverse reaction of glucose-6-phosphate back to glucose, pyruvate kinase, adenosine 5'-triphosphate and phosphate It is preferable to include phospho (enol) pyruvic acid.

The glycositol reaction reagent includes a buffer, a coloring agent, a surfactant, an oxidase, a peroxidase, and 4-aminoantipyrine, and reacts with 1,5-anhydroglucitol. The oxidase that produces hydrogen peroxide, pyranose oxidase, L-sorbose oxidase, L-sorbose dehydrogenase, 1,5-an It is preferably selected from the group consisting of 1,5-anhydroglucitol dehydrogenase and mixtures thereof, and is colored by reacting with the 4-aminoantipyrine which is oxidized through the enzymatic reaction between hydrogen peroxide and the peroxidase. The coloring agent is N-Ethyl-N- (2-hydroxy-3-sulfopropyl) -3,5-dimethylaniline (MAOS), N-Ethyl-N- (2-hydroxy-3-sulfopropyl) -3-methylaniline ( TOOS), N-Ethyl-N- (2-hydroxy-3-sulfopropyl) -3,5-dimethoxyaniline (DAO S), 3,3 '-, 5,5'-Tetramethylbenzidine, 3,3'-, 5,5'-Tetramethylbenzidine dihydrochloride, o-Toluidine, 3-methyl-2-benzothlazolinone hydrazone hydrochloride (MBTH), 8-anilino It is preferably selected from the group consisting of -1-naphthalenesulfonate (ANS) and mixtures thereof.

The above object also includes a glucose removal layer coated with a glucose removal reagent for converting glucose in a whole blood sample into glucose-6-phosphate; Glucositol reagent is coated with oxides formed by peroxidation reaction from hydrogen peroxide (H ₂ O ₂ ) produced by enzymatic reaction with 1,5-anhydroglucitol contained in the glucose-free sample. It is also achieved by means of 1,5-anhydroglucitol measuring means comprising a reaction layer.

Here, it is preferable that one end portion of the glucose removing layer and one end portion of the reaction layer are stacked between 20 and 40 length portions of 100 length portions, which are the entire length of the reaction layer.

According to the configuration of the present invention described above it is possible to color in the visible region through the enzyme reaction with 1,5- anhydroglucitol, and to measure the concentration of 1,5-anhydroglucitol inexpensively and simply through a visible light meter. It can be measured.

In addition, since glucose which causes the same enzymatic reaction as 1,5-anhydroglucinol can be removed from whole blood, 1,5-anhydroglucinol can be measured using whole blood as a sample as it is.

1 is a cross-sectional view of the 1,5-anhydroglucitol measuring means according to an embodiment of the present invention,
Figure 2 is a flow chart showing a method for producing 1,5- anhydroglucitol measuring means.

Hereinafter, the 1,5-anhydroglucitol measuring means and its preparation method according to the present invention will be described in detail with reference to the drawings.

As shown in FIG. 1, the 1,5-anhydroglucitol (1,5-AG) measuring means 10 includes a glucose removing layer 11 and a reaction layer 13. . The deglucose layer 11 is a layer in which the whole blood sample 1 is dropped and spread to remove glucose present in the whole blood sample 1. Glucose has the same enzymatic reaction as 1,5-anhydroglucinitol and thus interferes with accurate measurements in measuring 1,5-anhydroglucitol. Therefore, glucose is removed from the whole blood sample (1) to enable accurate measurement of 1,5-anhydroglucitol levels. The whole blood sample 1 dropped on the glucose removing layer 11 is moved to the reaction layer 13 in the state in which glucose is removed from the glucose removing layer 11. That is, the glucose removing layer 11 and the reaction layer 13 are coupled to each other so that the whole blood sample 1 from which glucose is removed can be moved to the reaction layer 13, and through an enzyme reaction in the reaction layer 13. An oxide is formed and developed. The oxidized oxide can be measured through a visible light meter to finally determine the amount of 1,5-anhydroglucitol. In this case, the whole blood sample is moved in the horizontal direction of the glucose removing layer 11 and the reaction layer 13 to measure the amount of 1,5-anhydroglucitol.

In the method of manufacturing 1,5-anhydroglucinitol measuring means as described above, as shown in FIG. 2, the glucose removing layer 11 is prepared (S1).

The oxidase, which is used to measure 1,5-anhydroglucitol, also reacts with glucose in the whole blood sample (1), so the glucose elimination reaction must be preceded. Therefore, after the preparation of glucose elimination reagent for converting glucose into glucose-6-phosphate for glucose elimination, the glucose elimination layer is applied by dipping the glucose eliminating body, which is a solid matrix, into the glucose eliminating reagent. (11) is formed.

As a solid matrix constituting the glucose removing body, a matrix made of glass fiber material is used. In the case of the glass fiber matrix, there is an advantage of keeping the sample 1 with a uniform component when the whole blood sample 1 is developed, and the effect of removing blood cells when the sample 1 is developed. For the glucose elimination body, it is preferable to use a glass fiber matrix having a thickness of 240 to 400 μm for rapid development of the whole blood sample 1. If the thickness of the glucose elimination body is less than 240㎛, the thickness of the glucose elimination reagent is not sufficiently applied, resulting in a case where glucose is not completely removed and remains. In addition, if the thickness exceeds 400㎛ has a disadvantage that the manufacturing cost increases because the thickness is thicker than necessary. The size of the glucose eliminating body is 5 mm in width and 20 to 40 mm in length, and the time for the whole blood sample 1 to reach the reaction layer 13 in 35 µL is 30 to 90 seconds.

Glucose eliminating reagents applied to the glucose eliminating body to convert glucose into glucose-6-phosphate include buffers, accelerators, glucose converting enzymes and reverse reaction eliminating reagents. In some cases, the accelerator may not be included in the glucose elimination reagent.

Buffers are used to create optimal conditions for enzymatic reactions, as well as to ensure that the pH of the colorant is not affected even when measuring samples having a pH value different from that of the reagent. The pH range of the preferred buffer of the present invention is 6.5 to 8.3, when the pH is less than 6.5, the color development sensitivity is low, and the amount of 1,5-anhydroglucitol cannot be properly measured, and when it exceeds 8.3, the color stability is poor. Has a problem. More preferred buffers have a pH of 6.1 to 7.0.

Buffers are HEPES (4- (2-Hydroxyethyl) piperazine-1-ethanesulfonic acid), PIPES (1,4-Piperazinediethanesulfonic acid), Tris (hydroxymethyl) aminomethane, MES (2-Morpholinoethanesulfonic acid) hydrate, Phosphate buffer And it may be selected from the group consisting of a mixture thereof. Among them, the HEPES buffer is most suitable in the present invention, and it is preferable that the concentration is 15 to 50 mM. The concentration of the buffer will have the same effect as the pH of the buffer. In other words, if the concentration of the buffer is less than 15mM enzyme reaction is not made smoothly and the interference of glucose in the reaction layer. In addition, even when the concentration of the buffer exceeds 50mM, the enzyme reaction is not smoothly performed, and thus glucose is not converted into glucose-6-phosphate, which causes glucose to remain. The most preferred concentration is 20 mM.

Magnesium sulfate is used as an accelerator, and magnesium sulfate is preferably added at a concentration of 10 to 40 mM. If the concentration of magnesium sulfate is less than 10mM does not function properly as an accelerator, if the concentration exceeds 40mM reaction rate is excessively fast may cause side reaction (side reaction).

Glucose converting enzyme means an enzyme that converts glucose into glucose-6-phosphate, and hexokinase or glucokinase having high specificity for glucose can be used. In the present invention, a reagent containing hexokinase is used, but glucokinase may be used. Here hexokinase or glucokinase enzyme is preferably included in the 50 to 500 ku / L, less than 50 ku / L glucose removal effect, if more than 500 ku / L waste enzyme because there is no further removal effect. The optimal concentration is 400 ku / L.

Reactions with hexokinase or glucokinase are reversible reactions and need to be removed. Without reverse reaction elimination, glucose-6-phosphate will return to glucose, making glucose removal easier. Therefore, in order to eliminate the reverse reaction, the glucose elimination reagent further includes a reverse reaction elimination reagent, and the reverse reaction elimination reagent includes pyruvate kinase, adenosine 5'-triphosphate and phosphoenol pyruvic acid (phospho). (enol) pyruvic acid).

The concentration of pyruvate kinase in the reaction reaction elimination reagent is in the range of 50 to 300 ku / L, and an appropriate concentration is 150 ku / L. Here, if the concentration of pyruvate kinase is less than 50 ku / L, the reverse reaction of glucose-6-phosphate may not be properly controlled, and if it exceeds 300 ku / L, the concentration of other components may be lowered to make an optimal reverse reaction elimination reagent. Adenosine 5'-triphosphate is included to be 5-40 mM, with the most preferred concentration being 20 mM. If the concentration of adenosine 5'-triphosphate is less than 5mM can not properly perform the role of the reaction reaction elimination reagent, even if it exceeds 40mM there is no further increase because there is no meaning added. In addition, the concentration of phosphoenol pyruvic acid is 10 to 50 mM, and the worry concentration is 20 mM. If the concentration of phosphoenol pyruvic acid is less than 10 mM, it is difficult to fully control the reverse reaction of glucose even if other components of the reverse reaction elimination reagent are increased.If the concentration of phosphoenol pyruvate exceeds 50 mM, the reagent is wasted because there is no increase in effect like adenosine 5'-triphosphate. do.

In some cases, the diffusion layer 15 may be further included on the glucose removing layer 11 to facilitate diffusion of the whole blood sample 1. The diffusion layer 15 is formed at an end portion of the glucose removing layer 11 that is not bonded to the reaction layer 13, and the whole blood sample 1 is dropped onto the diffusion layer 15, thereby spreading the sample 1 evenly. It is possible to allow glucose to be removed more effectively. The diffusion layer 15 is preferably made of a mesh (mesh), the size of the mesh is 200 to 300㎛. If the mesh size is less than 200 μm, the whole blood sample (1) does not spread quickly but remains agglomerated in the dropped position, and thus the glucose removal rate is slowed. It may not be. The size of such a diffusion layer is preferably 5mm horizontally and 5-10mm vertically.

To prepare a 1,5- anhydroglucitol reaction layer (S1 ').

A 1,5-anhydroglucinitol reaction layer is prepared separately from the step S1 of preparing the glucose removing layer 11. That is, the glucose removing layer 11 and the 1,5-anhydroglucinitol reaction layer 13 may be arranged together in one matrix, but are preferably manufactured separately for ease of manufacture. In the case of the reaction layer 13, the sample 1 from which glucose is removed is moved through the glucose removing layer 11 to confirm the amount of 1,5-anhydroglucinitol. As a method of confirming the amount of 1,5-anhydroglucitol through the reaction layer 13, 1,5-anhydroglucitol present in the sample 1 is oxidized in the reaction layer 13. It reacts with the enzyme to oxidize to produce hydrogen peroxide. The hydrogen peroxide thus obtained reacts with the color developer to form a purple coloring matter, and the coloring matter can be determined by measuring a numerical value through a visible light meter to determine the amount of 1,5-anhydroglucitol.

In this way, to prepare 1,5- anhydroglucitol to measure and oxidize 1,5- anhydroglucitol to prepare a glutitol reaction reagent, and then to a solid matrix of the glycitol reaction The main body is coated through a method of immersing in a glutathione reaction reagent to form a reaction layer 13.

It is preferable to use nylon 6,6 matrix for the solid matrix constituting the glutathione reaction body with excellent sample application and durability. Nylon 6,6 matrices have fast sample development rates even at low pressures, and can be applied to small amounts of samples, enabling the precise identification of minute amounts of 1,5-anhydroglucinol. It is preferable that the glutathione reaction body is formed with a thickness of 140 to 190 μm. If the thickness is less than 140 μm, the glycositol reaction reagent may not be sufficiently applied, and if it exceeds 190 μm, the thickness becomes thicker than necessary. There is a disadvantage that the amount of the coating of the glutathione reagent is increased, which increases the manufacturing cost. Glucitol reaction body is suitable for the size of 5mm horizontal, 5-10mm long, and complete the reaction within 60 to 180 seconds in the sample (1) developed through the glucose removal reaction layer (11).

GluCitol reaction reagents applied to the Glycitol reaction body to generate hydrogen peroxide through oxidation with 1,5-anhydroglucitol are buffers, colorants, surfactants, oxidases, peroxidases, and 4 4-aminoantipyrine.

Here, as the buffer used in the glucose elimination reagent, the buffer not only creates an optimal condition under which the enzymatic reaction can be properly performed, but also when the sample (1) having a pH value different from the pH of the prepared reagent is measured. It is used to prevent it from being affected. Such a buffer is preferably used in the same kind and concentration as the glucose elimination reagent, but in some cases different buffers may be used. It is preferable to use a buffer concentration of 50 to 300mM. If the concentration is less than 50mM, it is difficult to determine the exact amount of 1,5-anhydroglucitol because the enzymatic reaction is not performed smoothly. There is a problem that the enzyme reaction is not made smoothly. More preferred concentration is 100 to 150 mM. The type of such buffer may be selected from the types described in the glucose elimination reagent.

A chromophoric agent is added to enable 1,5-anhydroglucitol to react with the oxidase and to be identified in the visible region.It is a chromophore related to the spectroscopic measurement of hydrogen peroxide. desirable. Aniline reagents include N-Ethyl-N- (2-hydroxy-3-sulfopropyl) -3,5-dimethylaniline (MAOS) and N-Ethyl-N- (2-hydroxy-3-sulfopropyl) -3-methylaniline ( TOOS), N-Ethyl-N- (2-hydroxy-3-sulfopropyl) -3,5-dimethoxyaniline (DAOS), 3,3 '-, 5,5'-Tetramethylbenzidine, 3,3'-, 5,5 It is preferably selected from the group consisting of '-Tetramethylbenzidine dihydrochloride, o-Toluidine, 3-methyl-2-benzothlazolinone hydrazone hydrochloride (MBTH), 8-anilino-1-naphthalenesulfonate (ANS) and mixtures thereof. Among them, it is most preferable to use TOOS, which is a violet-based coloring agent having a wide interval measurement range, at a concentration of 1,5-anhydroglucitol is 0 to 100 mol / L. The concentration of the colorant is 5 to 20 mM, of which the optimal concentration is 10 to 15 mM. When the concentration of the colorant is less than 5mM, the color sensitivity of the measuring means is lowered, and when it exceeds 20mM, the color sensitivity is high, so that the color separation of hydrogen peroxide is lowered, thereby decreasing the sensitivity.

The surfactant serves to maintain the composition of the measuring means 10 in a dry state as a dispersing reagent, to stabilize the color change of the measuring means, to maintain the uniformity of the measuring means color change, and to increase the intensity of the measuring means color change. In this case, the surfactant uses 3-[(3-Cholamidopropyl) dimethylammonio] -1-propanesulfonate (CHAPS) which can increase the color intensity among various surfactants. Concentration of CHAPS is 5 to 10mM, the color increase is less than less than 5mM, if there is more than 10mM there is no further increase in the color development, there is a disadvantage that the surfactant is wasted when using a higher concentration.

Glucitol reagents include oxidases for the oxidation of 1,5-anhydroglucitol, and hydrogen peroxide is generated from 1,5-anhydroglucitol through enzymatic reaction with oxidase. The hydrogen peroxide and the color developer react with each other to confirm the amount of 1,5-anhydroglucitol. In this way, hydrogen peroxide is generated from 1,5-anhydroglucitol, and oxidase, peroxidase, and 4-aminoantipyrine are required for hydrogen peroxide to develop.

Oxidative enzymes that oxidize 1,5-anhydroglucinitol include pyranose oxidase, L-sorbose oxidase, and L-sorbose dehydrogenase. , 1,5-anhydroglucitol dehydrogenase (1,5-anhydroglucitol dehydrogenase), these may be used alone or in combination. In this case, the oxidase is preferably included at a concentration of 300 to 500 ku / L. If it is less than 300 ku / L, it is difficult to measure the exact amount because the 1,5-anhydroglucitol does not react entirely, and exceeds 500 ku / L. If oxidase is excessively added, there is a disadvantage in that the oxidase is wasted.

1,5-anhydroglucinol is oxidized through an oxidase to obtain hydrogen peroxide as a product. Glucitol reagents include peroxidase and 4-aminoantipyrine, and hydrogen peroxide reacts with the peroxidase enzyme to make 4-aminoantipyrine oxidized. This oxidized 4-aminoantipyrin reacts with TOOS, a color developer, to produce purple oxide. As such, the amount of purple oxide may be confirmed through a visible light meter, and the measured amount may be 1,5-anhydroglucinol. The concentration of the peroxidase enzyme is preferably 10 to 200 ku / L, but less than 10 ku / L, the reaction does not occur properly, and if it is 200 ku / L, it affects the ratio of the glycositol reaction reagent.

The glucose elimination layer 11 and the reaction layer 13 are combined (S2).

As shown in FIG. 2, the glucose removing layer 11 manufactured through the step S1 and the reaction layer 13 prepared through the step S1 'are combined. In some cases, the glucose removal layer 11 and the reaction layer 13 may be formed in one matrix. However, in consideration of the ease of applying the reagent, the glucose removal layer 11 and the reaction layer 13 may be prepared and then combined. It is preferable to make it. However, the glucose removing layer 11 and the reaction layer 13 may be formed together in one matrix.

One end of the glucose removing layer 11 formed along the lengthwise direction and one end of the reaction layer 13 are combined. Thereafter, when the whole blood sample 1 is dropped at the other end of the glucose removing layer 11, the whole blood sample 1 moves along the longitudinal direction of the glucose removing layer 11, and glucose is removed from the sample 1, and glucose is removed. The sample is removed is transferred to the reaction layer 13 coupled to one end of the glucose removing layer 11, the color is generated through the reaction in the reaction layer (13). Therefore, the reaction layer 13 is coupled to one end of the glucose removing layer 11 in the longitudinal direction, and drops the whole blood sample 1 to the other end of the glucose removing layer 11 which is not bonded to the reaction layer 13. It is preferable.

At this time, one end of the glucose removing layer 11 and one end of the reaction layer 13 is 20 to 40 of the 100 length part of the total length of the reaction layer 13 so that the whole blood sample 1 can be delivered to the reaction layer 13 It is preferable to combine so that the length part is laminated | stacked. If the area to be laminated is less than 20 length part, it is not easy to transfer the sample (1) to the reaction layer, so it takes a long time to check the amount of 1,5-anhydroglucitol. However, the length of the reaction layer 13 for the development of 1,5-anhydroglucitol is short, so that it is difficult to measure the exact amount of 1,5-anhydroglucitol.

In some cases, a support 17 may be further included below the combined glucose removing layer 11 and the reaction layer 13, and the support is most preferably made of a polyvinyl chloride (PVC) material. It is not limited.

Hereinafter, embodiments of the present invention will be described more clearly.

<Example>

Glucose-depleting reagents, including buffers, accelerators, glucose-converting enzymes, and reverse reaction-removing reagents, and glutes, including buffers, colorants, surfactants, oxidases, peroxidases, and 4-aminoantipyrine Prepare a tall reaction reagent. Glucose eliminating reagents and glycositol reaction reagents can be found in Tables 1 and 2 below.

Glucose Removal Reagent HEOES 20mM hexokinase 400ku / L ATP 20mM pyruvate kinase 300ku / L phospho (enol) pyruvic acid 20mM magnesium sulfate 20mM

Glucitol Reagent HEPES 120mM pyranose oxidase 60ku / L peroxidase 120ku / L TOOS 15 mM 4-aminoantipyrine 15 mM CHAPS 10 mM sodium azide 10 mM

The porous matrix prepared in the glucose removal reagent and the glutathione reaction reagent prepared at these components and concentrations is immersed to allow the respective components to sufficiently infiltrate. After removing the matrix from the glucose removal reagent and the glucose reaction reagent, excess reagents are removed with a glass rod, and dried for 10 minutes in a 40 ° C. hot air dryer to obtain a glucose removal layer and a reaction layer. The obtained glucose removing layer is cut into pieces of 5 mm in width and 30 mm in length, and the reaction layer is cut into pieces of 5 mm in width and 5 mm in length. The glucose removal layer and the reaction layer are arranged in the horizontal direction so that the development of the measurement sample becomes a horizontal flow, and the glucose removal layer and the reaction layer are laminated so that they overlap by about 1 mm, and finally, 1,5-anhydroglue is combined. Toll measuring means were prepared.

Table 3 and the results of comparing the 1,5- anhydroglucitol measuring means of the present invention prepared through such an example, and Lara 1,5-AG Auto Liquid product already established and used in the hospital It can be confirmed through FIG. As shown in the graph of FIG. 3, it can be seen that the correlation between the two products has a good correlation with y = 0.9821x + 1.5938 and a correlation coefficient (r) = 0.952.

Sample Invention (μg / mL) Lara 1,5-AG (μg / mL) One One 2 2 4 3 3 10 12 4 15 18 5 23 26 6 15 17 7 30 33 8 31 27 9 21 23 10 14 16

Conventional 1,5-anhydroglycitol measuring means is a method in which serum or plasma is required for blood cell separation as a sample, and is not suitable for self-measurement because a large amount of sample is required for measurement. On the other hand, the 1,5-anhydroglucitol measuring means of the present invention includes a layer for removing glucose in the measuring means, so that even if the whole blood sample is dropped as it is, the amount of 1,5-anhydroglucitol can be measured. It is very convenient for the user to use. In addition, in the conventional case, since it is impossible to measure the amount of 1,5-anhydroglucitol in the visible region, expensive equipment for measuring 1,5-anhydroglucitol is required. In contrast, in the case of the present invention, the absorbance may be measured through a small and inexpensive visible light source because it causes a reaction between 1,5-anhydroglucitol and an enzyme to be measured in the visible light region. As a result, the user can easily carry the device, and the measurement cost is low, thereby making it easy to measure 1,5-anhydroglucitol.

1: whole blood sample
10: measuring means
11: glucose removal layer
13: reaction layer
15: diffusion layer
17: support

Claims (12)

A deglucose-coated layer coated with a deglucose reagent that converts glucose in the whole blood sample to glucose-6-phosphate, and 1,5-anhydroglucinol and enzyme contained in the de-glucose sample Comprising a step of forming a reaction layer coated with a glutathione reactant to form an oxide from the hydrogen peroxide (H ₂ O ₂ ) produced by the reaction by the peroxide reaction,
The whole blood sample includes a diffusion layer on top of the glucose removing layer to facilitate diffusion into the glucose removing layer and the reaction layer. The whole blood sample is dropped on the diffusion layer, and the whole blood sample diffuses in a horizontal direction. By moving the glucose removing layer and the reaction layer through the amount of 1,5- anhydroglucitol is measured,
Forming a glucose removing layer by immersing a glucose removing body in the glucose removing reagent; Forming a reaction layer by immersing a glutathione reaction body in the glutathione reaction reagent; Further comprising combining the glucose removing layer and the reaction layer,
Combining the glucose removing layer and the reaction layer, the one end of the glucose removing layer formed along the longitudinal direction and the one end of the reaction layer are combined to be stacked,
A method for producing 1,5-anhydroglucitol measuring means, characterized in that the concentration of 1,5-anhydroglucinitol can be measured by a visible light meter. delete delete delete The method of claim 1,
The glucose removal reagent is,
A method for preparing 1,5-anhydroglucitol measuring means comprising a buffer, a promoter, a glucose converting enzyme and a reverse reaction elimination reagent. The method of claim 5,
The glucose converting enzyme for converting glucose into glucose-6-phosphate is 1,5-anhydroglucitol measurement, characterized in that selected from the group consisting of hexokinase, glucokinase and mixtures thereof Method of manufacturing means. The method of claim 5,
The reverse reaction elimination reagents for eliminating the reverse reaction of glucose-6-phosphate back to glucose include pyruvate kinase, adenosine 5'-triphosphate and phosphoenol pyruvic acid (enol). A pyruvic acid) 1,5- anhydroglucitol measuring means manufacturing method comprising a. The method of claim 1,
The glycitol reaction reagent,
Method for producing a 1,5- anhydroglucitol measuring means comprising a buffer, a coloring agent, a surfactant, an oxidase, peroxidase and 4-aminoantipyrine. The method of claim 8,
The oxidase, which reacts with 1,5-anhydroglucinitol to produce hydrogen peroxide, may be pyranose oxidase, L-sorbose oxidase, or L-sorbose dehydrogenase. (L-sorbose dehydrogenase), 1,5- anhydroglucitol dehydrogenase (1,5-anhydroglucitol dehydrogenase) and 1,5- anhydroglucitol, characterized in that selected from the group consisting of Method of manufacturing the measuring means. The method of claim 8,
The color developing agent reacted with the 4-aminoantipyrine oxidized through the enzymatic reaction between hydrogen peroxide and the peroxidase, N-Ethyl-N- (2-hydroxy-3-sulfopropyl) -3,5-dimethylaniline (MAOS) , N-Ethyl-N- (2-hydroxy-3-sulfopropyl) -3-methylaniline (TOOS), N-Ethyl-N- (2-hydroxy-3-sulfopropyl) -3,5-dimethoxyaniline (DAOS), 3 , 3 '-, 5,5'-Tetramethylbenzidine, 3,3'-, 5,5'-Tetramethylbenzidine dihydrochloride, o-Toluidine, 3-methyl-2-benzothlazolinone hydrazone hydrochloride (MBTH), 8-anilino-1-naphthalenesulfonate (ANS) and a method for producing 1,5-anhydroglucitol measuring means, characterized in that it is selected from the group consisting of. A glucose removal layer coated with a glucose removal reagent for converting glucose in the whole blood sample into glucose-6-phosphate;
Glucositol reagent is coated with oxides formed by peroxidation reaction from hydrogen peroxide (H ₂ O ₂ ) produced by enzymatic reaction with 1,5-anhydroglucitol contained in the glucose-free sample. Including a reaction layer,
The glucose removing layer and the reaction layer, the one end of the glucose removing layer formed along the longitudinal direction and the one end of the reaction layer are combined to be stacked,
The whole blood sample includes a diffusion layer on top of the glucose removal layer to facilitate diffusion into the glucose removal layer and the reaction layer,
Dropping the whole blood sample on top of the diffusion layer, the whole blood sample is moved to the glucose removing layer and the reaction layer through the diffusion in a horizontal direction, the amount of 1,5- anhydroglucitol is measured,
The 1, 5- anhydroglucitol measuring means characterized by being able to measure the density | concentration of 1, 5- anhydroglucitol by a visible light meter. The method of claim 11,
One end portion of the glucose removing layer and one end portion of the reaction layer 1,5- anhydroglucitol measuring means, characterized in that 20 to 40 length part of the total length 100 of the reaction layer is laminated.

Images